As a nonprofit, FCF is fueled by donors like you. By supporting FCF this Giving Tuesday, you can play a crucial role in funding the groundbreaking research necessary to find improved treatment options for fibrolamellar cancer patients. In the last 2 years alone, FCF has approved $9.8 million in new FLC research and clinical trials at world-class institutions throughout the U.S. and Europe. We need your help to maintain that pace of investment.

Thanks to the generosity of Chuck and Marna Davis, all dollars donated between now and January 31, 2024, will be matched 1:1. As always, 100% of donations to FCF directly fund research efforts.

Together, we can make a difference in the fight against this rare cancer. Please click here to donate. Thank you!